Pleural effusions in hematologic malignancies

Chest

Volumn 125, Issue 4, 2004, Pages 1546-1555

  Alexandrakis, Michael G ^a   Passam, Freda H ^b   Kyriakou, Despina S ^c   Bouros, Demosthenes ^d,e  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Leukemia; Lymphoma; Pleural fluid; Pleural infiltration

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; STEROID;

ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; CYTOLOGY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MALIGNANT PLASMACYTOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NEEDLE BIOPSY; NONHODGKIN LYMPHOMA; PATHOPHYSIOLOGY; PERTHES DISEASE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURODESIS; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THORAX RADIOGRAPHY;

EID: 11144353217     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.4.1546     Document Type: Review

References (134)

1. Berkman N, Breuer R, Kramer MR, et al. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996; 20:229-237
2. Johnston WW. The malignant pleural effusion: a review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985; 56:905-909
3. Light RW, Erozan YS, Ball WC. Cells in pleural fluid. Arch Intern Med 1973; 132:854-860
4. Lossos IS, Intrator O, Berkman N, et al. Lactate dehydrogenase isoenzyme analysis for the diagnosis of pleural effusion in haemato-oncological patients. Respir Med 1999; 93:338-341
5. Suster S, Moran CA. Pleomorphic large cell lymphoma of the mediastinum. Am J Surg Pathol 1996; 20:224-232
6. Kodama K, Yokose T, Takahashi K, et al. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the lung: a report of a case with pleural dissemination. Lung Cancer 1999; 24:175-178
7. Elis A, Blickstein D, Mulchanov I, et al. Pleural effusion in patients with non-Hodgkin's lymphoma: a case-controlled study. Cancer 1998; 83:1607-1611
8. Higgins JP, Shuttari M, Demmy T, et al. Diffuse large cell lymphoma of the lung: an unusual cause of complete opacification of the hemithorax. South Med J1994; 87:1183-1185
9. Pietsch JB, Whitlock JA, Ford C, et al. Management of pleural effusions in children with malignant lymphoma. J Pediatr Surg 1999; 34:635-638
10. Moriki T, Wada M, Takahashi T, et al. Pleural effusion cytology in a case of cytophagic histiocytic panniculitis (subcutaneous panniculitic T-cell lymphoma): a case report. Acta Cytol 2000; 44:1040-1044
11. Bangerter M, Hildebrand A, Griesshammer M. Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions. Acta Cytol 2001; 45:307-312
12. Chagnaud BE, Bonsack TA, Kozakewick HP, et al. Pleural effusions in lymphoblastic lymphoma: a diagnostic alternative. J Pediatr Surg 1998; 33:1355-1357
13. Sakemi T, Uchida M, Ikeda Y, et al. Acute renal failure and nephrotic syndrome in a patient with T-cell lymphoma. Nephron 1996; 72:326-327
14. Collins J, Muller NL, Leung An, et al. Epstein-Barr virus associated lymphoproliferative disease of the lung: CT and histological findings. Radiology 1998; 208:749-759
15. Aquino SL, Chen MY, Kuo WT, et al. The CT appearance of pleural and extra-pleural disease in lymphoma. Clin Radiol 1999; 54:647-650
16. Ooi GC, Chim CS, Lie AK, et al. Computed tomography features of primary pulmonary non-Hodgkin's lymphoma. Clin Radiol 1999; 54:438-443
17. Xaubet A, Diumenjo MC, Marin A, et al. Characteristics and prognostic value of pleural effusions in non-Hodgkin's lymphomas. Eur J Respir Dis 1985; 66:135-140
18. Valdes L, Alvarez D, Valle JM, et al. The aetiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996; 109:158-162
19. Van Renterghem DM, Pauwels RA. Chylothorax and pleural effusions as late complications of thoracic irradiation. Chest 1995; 108:874-886
20. Karadeniz C, Guven MA, Ruacan S, et al. Primary pleural lymphoma: an unusual presentation of childhood non-Hodgkin's lymphoma. Pediatr Hematol Oncol 2000; 17:695-699
21. Yasuda H, Nakao M, Kanemasa H, et al. T-cell lymphoma presenting with pericardial and pleural effusions as the initial and primary lesion: cytogenetic and molecular evidence. Intern Med 1996; 35:150-154
22. Bangerter M, Hildebrand A, Griesshammer M. Immunophenotypic analysis of simultaneous specimens from different sites of the same patient with malignant lymphoma. Cytopathology 2001; 12:168-176
23. Laurini JA, Garcia A, Elsner B, et al. Relation between natural killer cells and neoplastic cell in serous fluids. Diagn Cytopathol 2000; 22:347-350
24. Green LK, Griffin J. Increased natural killer cells in fluids: a new sensitive means of detecting carcinoma. Acta Cytol 1996; 40:1240-1245
25. Matolsky A, Nador RG, Cesarman E, et al. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B-cell maturation. Am J Pathol 1998; 153:1609-1614
26. Patriarcha F, Ermacora A, Skert C. Pleural involvement in a case of monocytoid B-cell lymphoma. Haematologica 1999; 84:949-950
27. Morel P, Dupriez B, Plantier-Colcher I, et al. Long-term outcome of follicular low-grade lymphoma: a report of 91 patients. Ann Hematol 1993; 66:303-308
28. Siegert W, Nerl C, Agthe A, et al. Angioimmunoblastic lymphadenopathy (AILD)-type-T cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation; the Kiel Lymphoma Study Group. Ann Oncol 1995; 6:659-664
29. Shepherd SF, A'Hern RP, Pinkerton CR. Childhood T-cell lymphoblastic lymphoma: does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG). Br J Cancer 1995; 72:752-756
30. Sundlund JT, Grist WM, Abramowitch M, et al. Pleural effusion is associated with a poor treatment outcome in stage III small non-cleaved cell lymphoma. Leukemia 1991; 5:71-74
31. Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993; 11:1336-1343
32. Vu HW, Jenkins FW, Swerdlow SH, et al. Pleural effusion as the presentation for primary effusion lymphoma. Surgery 1998; 123:589-591
33. Ray P, Antoine M, Mary-Krause M, et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998; 158:1221-1229
34. Nador R, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88:645-656
35. Iwahashi M, Lida S, Sako S, et al. Primary effusion lymphoma with B-cell phenotype. Am J Hematol 2000; 64:317-318
36. Light RW, Hamin H. Pleural disease and acquired immune deficiency syndrome. Eur Respir J 1997; 10:2638-2643
37. Ascoli V, Mastroianni CM, Galati V, et al. Primary effusion lymphoma containing human herpesvirus 8 DNA in two AIDS patients with Kaposi's sarcoma. Haematologica 1998; 83:8-12
38. Beck JM. Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 1998; 19:341-349
39. Lacoste V, Judde JG, Bestett G, et al. Virological and molecular characterization of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harboring both KSHV/HHV8 and EBV viruses. Leuk Lymphoma 2000; 38:401-409
40. Carbone A, Gaidano G. HHV-8 positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97:515-522
41. Ansari MQ, Dawson DB, Nador R, et al. Primary body-cavity-based AIDS related lymphomas. Am J Clin Pathol 1996; 105:221-229
42. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma associated herpes virus (KSHV/HHV-8) in the absence of Epstein-Barr-virus. Blood 1996; 88:2648-2654
43. Klephish A, Sarid R, Shtalrid M, et al. Primary effusion lymphoma (PEL) in HIV negative patients: a distinct clinical entity. Leuk Lymphoma 2001; 41:439-443
44. Casado Farinas I, Alonso Martin MS, Gomez Aguado F, et al. Primary effusion lymphoma associated with type-8 human virus infection. Ann Intern Med 2000; 17:366-368
45. Ascoli V, Siriani MC, Mezzaroma I, et al. Human herpesvirus-8 in lymphomatous and non-lymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. Ann Diagn Pathol 1999; 3:357-363
46. Jones D, Weinberg DS, Pinkus GS, et al. Cytologic diagnosis of primary serous lymphoma. Am J Clin Pathol 1996; 106:359-364
47. Fukayama M, Ikuba T, Hayashi Ooba T, et al. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 1993; 143:1044-1049
48. Aozasa K. Pyothorax-associated lymphoma. Int J Hematol 1996; 65:9-16
49. Kanno H, Yosunaga Y, Iuchi K, et al. Interleukin 6-mediated growth enhancement of cell lines derived from pyothoraxassociated lymphoma. Lab Invest 1996; 75:167-173
50. Daibata M, Taguchi T, Nemoto Y, et al. Epstein-Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL) chromosomal integration of EBV in a novel CD2-positive PAL B-cell line. Br J Haematol 2002; 117:546-557
51. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions under cyclosporine-steroid therapy. Lancet 1984; 1:979-981
52. O'Donovan M, Silva L, Uhlam V, et al. Expression profile of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in effusion lymphoma. Mol Pathol 2001; 54:80-85
53. Sarid R, Klepfish A, Schattner A. Virology, pathogenetic mechanisms and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc 2002; 77:941-949
54. Awotedu A, Otulana B, Ukoli C. Giant lymph node hyperplasia of the lung (Castleman's disease) associated with recurrent pleural effusion. Thorax 1990; 45:775-776
55. Gillison ML, Ambinder RF. Human herpesvirus-8. Curr Opin Oncol 1997; 9:440-449
56. Blankenship M, Rowlett J, Timby J, et al. Giant lymph node hyperplasia (Castleman's disease) presenting with chylous pleural effusion. Chest 1997; 112:1132-1133
57. Hoor TT, Hewan;Lowe K, Miller I, et al. A transitional variant of Castleman's disease presenting as a chylous effusion. Chest 1999; 115:285-288
58. Bernardeschi P, Bonechi I, Urbano U. Recurent pleural effusion as manifesting features of primitive chest wall Hodgkin's disease. Chest 1988; 94:424-426
59. Bilgin G, Yilmaz AS, Koksal E, et al. Primary chest Hodgkin's disease diagnosed by pleura biopsy: case report. East Afr Med J 2001; 78:389-391
60. Olson PR, Silverman JF, Powers CN. Pleural fluid cytology of Hodgkin's disease: cytomorphologic features and the value of immunohistochemical studies. Diagn Cytopathol 2000; 22:21-24
61. Kramer G, Gans S, Rijnders A, et al. Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicate. Lung Cancer 2000; 27:205-208
62. Rodriguez-Garcia JL, Guadalupe F, Moreno MA, et al. Recurrent massive pleural effusion as a late complication of radiotherapy in Hodgkin's disease. Chest 1991; 100:1165-1166
63. Morrone N, Gama e Silva Volpe VL, Dourado AM, et al. Bilateral pleural effusion due to mediastinal fibrosis induced by radiotherapy. Chest 1993; 104:1276-1278
64. Sahn SA. The pleura. Am Rev Respir Dis 1988, 138:184-234
65. Van Renterghen DM, Pauwels RA. Chylothorax and pleural effusion as late complications of thoracic irradiation. Chest 1995; 108:886-887
66. Shalev A, Borer H, Reusser P, et al. Chylothorax as the initial manifestation of malignant Hodgkin's lymphoma [in German]. Schweiz Rundsch Med Prax 1998; 87:690-693
67. Kennedy L, Sahn S. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106:1215-1222
68. Vargas FS, Milanez JR, Filomeno LT, et al. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 1994; 106:1771-1775
69. Dix DB, Anderson RA, Mc Fadden DE, et al. Pleural relapse during haematopoietic remission in childhood acute lymphoblastic leukaemia. J Pediatr Hematol Oncol 1997; 19:470-472
70. Rege K, Powles C, Norton J, et al. An unusual presentation of acute myeloid leukemia with pericardial and pleural effusions due to granulocytic sarcoma. Leuk Lymphoma 1993; 11:305-307
71. Bunin NJ, Pui C-H, Husto HO, et al. Unusual extramedullary relapses in children with acute lymphoblastic leukemia. J Pediatr 1986; 109:665-668
72. Murray JC, Gmoser DJ, Barnes DA, et al. Isolated bone relapse during hematological remission in childhood acute lymphoblastic leukemia: report of a metatarsal relapse and review of the literature. Med Pediatr Oncol 1994; 23:153-157
73. Schmetzer HM, Wilmanns W, Gerhartz HH. Detection of acute myeloid leukemia cells in complete remission and in extramedullary sites by clonal analyses. Acta Haematol 1996; 96:83-87
74. Bouronche BA. Unusual presentations and complications of hairy cell leukemia. Leukemia 1987; 1:288-293
75. Fukushima Y, Miyakuni T, Yoshida K, et al. Pleural effusion in a case of plasma cell leukemia after undergoing simple total hysterectomy for uterine cervical carcinoma: review of multiple myeloma and plasma cell leukemia effusion in Japan [in Japanese]. Rinsho Ketsueki 1987; 28:1424-1429
76. Aasebo U, Norum J, Sager G, et al. Intrapleurally instilled mitoxantrone in metastatic pleural effusions: a phase II study. J Chemother 1997; 9:106-111
77. Light RW. Malignant pleural effusions. In Light RW, ed. Pleural diseases. Philadelphia, PA: Lea & Febiger, 1990; 97-116
78. Horn KD, Penchansky L. Chylous pleural effusions simulating leukemia infiltrate associated with thoracoabdominal disease and surgery in infants. Am J Clin Pathol 1999; 111:99-104
79. Yam LT. Granulocytic sarcoma with pleura involvement: identification of neoplastic cells with cytometry. Acta Cytol 1985; 29:63-66
80. Matyskova M, Krahulcova E, Bulikova A, et al. Pleural effusion in plasmacytic leukemia [in Czech]. Vnitr Lek 1995; 41:467-469
81. Bronner GM, Baas P, Beijnen JH. Pleurodesis in malignant pleural effusion [in Dutch]. Ned Tijdschr Geneeskd 1997; 141:1810-1814
82. Ben-Chetrit, Assaf Y, Shinar E. Predominant T-cells in pleural effusion of a patient with B-cell CLL. Acta Haematol 1985; 73:101-103
83. Shimoni A, Shvidel L, Shtalrid M, et al. Prolymphocytic transformation of B-chronic lymphocytic leukaemia presenting as malignant ascites and pleural effusion. Am J Hematol 1998; 59:316-318
84. Van den Berge M, Tinga CJ, Bieger R. A 73-year-old man with chronic lymphocytic leukemia and a haemorrhagic pleural effusion. Ann Haematol 2001; 80:183-186
85. Lucivero G, Pierucci G, Dell'Osso A, et al. B-cell chronic lymphocytic leukemia and lung carcinoma with T-lymphocyte-rich pleural effusion in a single patient. Acta Haematol 1986; 75:110-112
86. Miyahara M, Shimamoto Y, Sano M, et al. Immunoglobulin gene rearrangement in T-cell-rich reactive pleural effusion of a patient with B-cell chronic lymphocytic leukaemia. Acta Haematol 1996; 96:41-44
87. Swerdlow SH, Zellner DC, Hurtubise PE, et al. Pleural involvement in B-cell chronic lymphocytic leukaemia associated with a T-cell-rich "reactive" pleural effusion. Am J Respir Dis 1986; 134:172-174
88. Bourantas KL, Repousis P, Tsiara S, et al. Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia case report. J Exp Clin Cancer Res 1998; 17:234-235
89. Mohapatra MK, Das SP, Mohanty NC, et al. Hemopericardium with cardiac tamponade and pleural effusion in chronic myeloid leukemia. Indian Heart J 2000; 52:209-211
90. Chubachi A, Wakui H, Miura I, et al. Extramedullary megakaryoblastic tumors following an indolent phase of myelofibrosis. Leuk Lymphoma 1995; 17:351-354
91. De Renzo A, Miceva V, Vaglio S, et al. Induction of alkaline phosphatase activity in chronic myeloid leukemia cells: in vitro studies and speculative hypothesis. Am J Hematol 1990; 35:278-280
92. Hicsonmez G, Cetin M, Tunc B, et al. Dramatic resolution of pleural effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone. Leuk Lymphoma 1998; 29:617-623
93. Petit A, Pulik M, Gaulier A, et al. Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon a therapy. J Am Acad Dermatol 1995; 32;850-853
94. Farrel SA, Warda LJ, Laflair P, et al. Adams-Oliver syndrome: a case with juvenile chronic myelogenous leukemia and chylothorax. Am J Med Genet 1993; 47:1175-1179
95. Mufti GJ, Oscier DG, Hamblin TJ, et al. Serous effusions in monocytic leukemias. Br J Haematol 1994; 58:547-552
96. Manoharan A. Malignant pleural effusion in chronic myelomonocytic leukemia. Thorax 1991; 46:461-462
97. Bourantas KL, Tsiara S, Panteli A, et al. Pleural effusion in chronic myelomonocytic leukemia. Acta Haematol 1998; 99:34-37
98. Motoji T, Teramura M, Takahashi M, et al. Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol 1990; 33:8-12
99. Hisconmez G, Tuncer AM, Sayli T, et al. High-dose methylprednisolone, low-dose arabinoside and mitoxantrone in children with myelodysplastic syndromes. Hematol Pathol 1995; 9:185-193
100. Matsushima T, Murakami H, Kim K, et al. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der (1q; 7p) chromosomal abnormality. Am J Hematol 1995; 50:110-115
101. Mufti GJ, Figes A, Hamblin TJ, et al. Immunological abnormalities in myelodysplastic syndromes: serum immunoglobulins and autoantibodies. Br J Haematol 1986; 63:143-147
102. Economopoulos T, Economidou J, Giannopoulos G, et al. Immune abnormalities in myelodysplastic syndromes. J Clin Pathol 1995; 38:908-911
103. Billstrom R, Johansson H, Johansson B, et al. Immune-mediated complications in patients with myelodysplastic syndromes: clinical and cytogenetic features. Eur J Haematol 1995; 58:42-48
104. Kintzer JS, Rosenow EC, Kyle RA. Thoracic and pulmonary abnormalities in multiple myeloma. Arch Intern Med 1978; 138:727-730
105. Rodriquez JN, Pereira A, Martinez JC, et al. Pleural effusion in multiple myeloma. Chest 1994; 105:622-624
106. Manley R, Monteath J, Patton WN. Co-incidental presentation of IgAλ multiple myeloma and pleural involvement with IgMκ non-Hodgkin's lymphoma. Clin Lab Haematol 1999; 21:61-63
107. Hughes JC, Votaw ML. Pleural effusion in multiple myeloma. Cancer 1979; 44:1150-1154
108. Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of effusions of multiple myeloma. Diagn Cytopathol 2000; 22:147-151
109. Deshpande AH, Munshi MM. Pleural effusion as an initial manifestation of multiple myeloma. Acta Cytol 2000; 44: 103-104
110. Pacheco A, Perpina A, Escribano L, et al. Pleural effusion as the first sign of extramedullary plasmacytoma. Chest 1992; 102:296-297
111. Nagai K, Audo K, Yoshima H, et al. Response of the extramedullary lung plasmacytoma with pleural effusion to chemotherapy. Ann Hematol 1997; 74:279-281
112. Maeno T, Sando Y, Tsukagoshi M, et al. Pleural amyloidosis in a patient with intractable pleural effusion and multiple myeloma. Respirology 2000; 5:79-80
113. Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. Ann Intern Med 1996; 124:407-413
114. Kyrtsonis MC, Angelopoulou MK, Kontopidou FN, et al. Primary lung involvement in Waldenström's macroglobulinaemia: report of two cases and review of the literature. Acta Haematol 2001; 105:92-96
115. Stevenet P, Stevenet A, Helias A, et al. Pleural manifestations of secondary monoclonal dysproteinemia (apropos of 4 cases) [in French]. Poumon Coeur 1977; 33:143-148
116. Noble PW, The pulmonary complications of bone marrow transplantation in adults. West J Med 1989; 150:443-449
117. Seber A, Khan S, Kersey J. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft versus host disease. Bone Marrow Transplant 1996; 17:207-211
118. Schwarer AP, Huges JMB, Trotman-Dickenson B, et al. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54:1002-1008
119. Ueda T, Manabe A, Kikuchi A, et al. Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation. Int J Hematol 2000; 71:394-397
120. Lechapt-Zalcman E, Rieux C, Cordonnier C, et al. Post-transplantation lymphoproliferative disorder mimicking a nonspecific lymphocytic pleural effusion in a bone marrow transplant recipient. Acta Cytol 1999; 43:239-242
121. Edmonson JH, Hartmann LC, Long HJ, et al. Granulocyte-macrophage colony-stimulating factor: preliminary observations on the influence of dose, schedule and route of administration in patients receiving cycloplosphamide and carboplatin. Cancer 1992; 70:2529-2539
122. Schaap N, Rymakers R, Schattenberg A, et al. Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT. Bone Marrow Transplant 1996; 18:247-248
123. Ozkaynak MF, Weiberg K, Kohn D, et al. Hepatic venoocclusive disease post bone marrow transplantation in children conditioned with busulphan and cyclophosphamide: incidence, risk factors and clinical outcome. Bone Marrow Transplant 1991; 7:467-474
124. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. Am J Med 1980; 69: 204-217
125. Harris N, Ferry J, Swerdlows S. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology workshop. Semin Diagn Pathol 1997; 14:8-14
126. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lympho-proliferative disorders. Blood 1995; 85:552-565
127. Hanson MN, Morrison VA, Peterson BA, et al. Posttransplant T-cell lymphoproliferative disorders: an aggressive late complication of solid-organ transplantation. Blood 1996; 88:3626-3633
128. Jimenez-Heffernan JA, Viguer JM, Vicandi B, et al. Post-transplant CD 30 (Ki-1)-positive anaplastic large cell lymphoma. Acta Cytol 1997; 41:1519-1524
129. Lucas KG, Small TN, Heller G, et al. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 1996; 87:2594-2603
130. Papadopoulos E, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Barr-virus-associated lymphoproliferative disorders after allogenic bone marrow transplantation. N Engl J Med 1994; 330:1185-1191
131. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18:177-184
132. Oeda E, Shinohara K, Kamei S, et al. Capillary leak syndrome likely the result of granulocyte colony stimulating factor after high-dose chemotherapy. Intern Med 1994; 33:115-119
133. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 1990; 75:1011-1016
134. Antin JH, Ferrara LM. Cytokine dysregulation and acute graft versus host disease. Blood 1992; 80:2964-2968